AIGH Capital Management LLC - Q4 2021 holdings

$328 Million is the total value of AIGH Capital Management LLC's 98 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 69.2% .

 Value Shares↓ Weighting
SIMO SellSILICON MOTION TECHNOLOGY COsponsored adr$34,686,000
+19.1%
365,000
-75.1%
10.58%
+72.7%
PDFS  PDF SOLUTIONS INC$31,949,000
+38.0%
1,005,0000.0%9.74%
+100.0%
PLAB SellPHOTRONICS INC$23,390,000
+25.2%
1,240,869
-9.5%
7.13%
+81.5%
CYBE BuyCYBEROPTICS CORP$23,204,000
+459.5%
499,017
+328.1%
7.08%
+711.4%
ADTN BuyADTRAN INC$19,804,000
+29.9%
867,456
+6.7%
6.04%
+88.3%
DZSI BuyDZS INC$18,974,000
+59.7%
1,169,799
+20.7%
5.78%
+131.6%
MRAM NewEVERSPIN TECHNOLOGIES INC$17,572,0001,555,026
+100.0%
5.36%
SCYX BuySCYNEXIS INC$12,988,000
+614.0%
2,129,045
+520.5%
3.96%
+933.9%
AVNW SellAVIAT NETWORKS INC$12,242,000
-32.8%
381,618
-31.2%
3.73%
-2.6%
AVEO BuyAVEO PHARMACEUTICALS INC$11,990,000
-2.3%
2,556,600
+28.7%
3.66%
+41.7%
PRTK BuyPARATEK PHARMACEUTICALS INC$10,502,000
+34.3%
2,339,107
+45.3%
3.20%
+94.7%
THTX SellTHERATECHNOLOGIES INC$8,718,000
-27.1%
2,883,167
-4.6%
2.66%
+5.6%
EDAP SellEDAP TMS S Asponsored adr$7,179,000
-6.9%
1,198,529
-0.8%
2.19%
+35.0%
SCPH BuySCPHARMACEUTICALS INC$6,893,000
-16.0%
1,373,124
+11.3%
2.10%
+21.8%
NewPARABELLUM ACQUISITION CORPcall$5,746,000589,286
+100.0%
1.75%
MIRM NewMIRUM PHARMACEUTICALS INC$5,389,000337,917
+100.0%
1.64%
LTRX NewLANTRONIX INC$5,389,000688,309
+100.0%
1.64%
MYO BuyMYOMO INC$4,120,000
-0.5%
601,929
+72.9%
1.26%
+44.4%
WTT  WIRELESS TELECOM GROUP INC$4,109,000
+6.3%
1,867,6390.0%1.25%
+54.1%
RFIL  RF INDS LTD$3,960,000
-1.9%
495,0370.0%1.21%
+42.2%
OIIM SellO2MICRO INTERNATIONAL LIMITEspons adr$3,946,000
-73.4%
871,051
-64.6%
1.20%
-61.5%
MDNA BuyMEDICENNA THERAPEUTICS CORP$3,612,000
+42.0%
2,214,300
+142.0%
1.10%
+105.8%
XFOR SellX4 PHARMACEUTICALS INC$3,353,000
-61.9%
1,464,099
-12.0%
1.02%
-44.8%
LPTH NewLIGHTPATH TECHNOLOGIES INC$3,344,0001,370,580
+100.0%
1.02%
HTGM  HTG MOLECULAR DIAGNOSTICS IN$3,317,000
-5.1%
612,0000.0%1.01%
+37.6%
BKTI  BK TECHNOLOGIES CORPORATION$3,229,000
-14.7%
1,340,0000.0%0.98%
+23.7%
RNAZ BuyTRANSCODE THERAPEUTICS INC$3,228,000
-15.0%
1,270,600
+0.0%
0.98%
+23.2%
NBSE NewNEUBASE THERAPEUTICS INC$2,811,0001,000,285
+100.0%
0.86%
ARDX NewARDELYX INC$2,642,0002,401,807
+100.0%
0.81%
SellALIMERA SCIENCES INC$2,553,000
+20.7%
497,639
-0.7%
0.78%
+74.8%
PDSB SellPDS BIOTECHNOLOGY CORP$2,496,000
-78.3%
308,034
-60.2%
0.76%
-68.6%
BuyIDEAL PWR INC$2,409,000
+9.6%
199,732
+38.4%
0.74%
+59.1%
ALNA  ALLENA PHARMACEUTICALS$2,370,000
-34.3%
4,000,0000.0%0.72%
-4.7%
EMKR SellEMCORE CORP$2,048,000
-91.9%
293,349
-91.3%
0.62%
-88.2%
NewCONTEXT THERAPEUTICS INC$2,028,000762,721
+100.0%
0.62%
BLIN SellBRIDGELINE DIGITAL INC$1,982,000
-88.5%
877,193
-30.4%
0.60%
-83.3%
FKWL SellFRANKLIN WIRELESS CORP$1,704,000
-69.9%
390,000
-50.0%
0.52%
-56.3%
YTEN  YIELD10 BIOSCIENCE INC$1,683,000
-17.9%
342,0000.0%0.51%
+19.0%
BWAY SellBRAINSWAY LTDsponsored ads$1,600,000
-54.9%
207,847
-52.8%
0.49%
-34.6%
PCSA SellPROCESSA PHARMACEUTICALS INC$1,488,000
-55.1%
303,703
-21.5%
0.45%
-35.0%
HSDT NewHELIUS MED TECHNOLOGIES INC$1,298,000250,000
+100.0%
0.40%
RZLT NewREZOLUTE INC$1,267,000265,181
+100.0%
0.39%
CYTHW NewCYCLO THERAPEUTICS INCcall$1,100,000294,931
+100.0%
0.34%
NMTC NewNEUROONE MED TECHNOLOGIES CO$921,000475,000
+100.0%
0.28%
NLSPW  NLS PHARMACEUTICS LTDcall$919,000
-55.6%
827,9210.0%0.28%
-35.6%
CLRB NewCELLECTAR BIOSCIENCES INC$596,000896,590
+100.0%
0.18%
ABEO NewABEONA THERAPEUTICS INC$383,0001,137,274
+100.0%
0.12%
NewPETVIVO HLDGS INCcall$377,000100,000
+100.0%
0.12%
NewDERMATA THERAPEUTICS INCcall$305,000175,000
+100.0%
0.09%
NewCOGNITION THERAPEUTICS INC$161,00025,496
+100.0%
0.05%
PETV ExitPETVIVO HLDGS INC$0-50,000
-100.0%
-0.03%
PETV ExitPETVIVO HLDGS INCcall$0-100,000
-100.0%
-0.06%
ARDS ExitARIDIS PHARMACEUTICALS INC$0-150,591
-100.0%
-0.12%
ExitDERMATA THERAPEUTICS INCcall$0-175,000
-100.0%
-0.16%
ExitDERMATA THERAPEUTICS INC$0-175,000
-100.0%
-0.16%
NUWE ExitNUWELLIS INC$0-760,000
-100.0%
-0.35%
ONDS ExitONDAS HLDGS INC$0-207,070
-100.0%
-0.40%
ANVS ExitANNOVIS BIO INC$0-66,469
-100.0%
-0.44%
EVOK ExitEVOKE PHARMA INC$0-1,701,185
-100.0%
-0.46%
CYTH ExitCYCLO THERAPEUTICS INCcall$0-350,000
-100.0%
-0.50%
ACTG ExitACACIA RESH CORP$0-362,906
-100.0%
-0.52%
DAIO ExitDATA I O CORP$0-418,310
-100.0%
-0.57%
ASYS ExitAMTECH SYS INC$0-273,100
-100.0%
-0.66%
AMSC ExitAMERICAN SUPERCONDUCTOR CORP$0-395,487
-100.0%
-1.21%
AVYA ExitAVAYA HLDGS CORPcall$0-300,000
-100.0%
-1.25%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-864,427
-100.0%
-1.27%
ADMS ExitADAMAS PHARMACEUTICALS INC$0-2,585,743
-100.0%
-2.67%
GRTX ExitGALERA THERAPEUTICS INC$0-2,036,495
-100.0%
-3.47%
IWM ExitISHARES TRput$0-500,000
-100.0%
-23.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AVIAT NETWORKS INC12Q3 20236.8%
SCPHARMACEUTICALS INC12Q3 20238.5%
THERATECHNOLOGIES INC11Q2 20232.9%
FRANKLIN WIRELESS CORP11Q3 20232.9%
IDEAL PWR INC11Q3 20232.5%
MEDICENNA THERAPEUTICS CORP11Q3 20231.1%
PARATEK PHARMACEUTICALS INC10Q1 20233.2%
LIGHTPATH TECHNOLOGIES INC10Q3 20233.0%
MYOMO INC10Q3 20231.3%
DZS INC9Q1 20237.5%

View AIGH Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
AIGH Capital Management LLC Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bridgeline Digital, Inc.May 21, 2021627,4199.7%

View AIGH Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-15
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-11-12

View AIGH Capital Management LLC's complete filings history.

Compare quarters

Export AIGH Capital Management LLC's holdings